ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 127

Diet Change and Omega-3 Supplementation in the First Three Years Following a Diagnosis with Rheumatoid Arthritis in Sweden

Maxine Lancelot1,2, Olivier Grimaud3, Saedis Saevarsdottir4, Johan Askling5, Lars Klareskog6, Lars Alfredsson7 and Camilla Bengtsson8, 1IMM, Karolinska Institutet, Stockholm, Sweden, 2EHESP, Paris, France, 3EHESP, Rennes, France, 4Rheumatology Unit, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, 5Unit of Clinical Epidemiology, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, 6Dept. of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, 7The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, 8Inst of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: dietary supplements, nutrition and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Epidemiology and Public Health Poster I: Rheumatoid Arthritis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Major dietary modification and omega-3 supplements are often promoted on patient counseling websites for those with RA. Given uncertainty regarding such approaches, we aim to study the frequency and characteristics of patients who undertake these complementary measures. 

Methods:

Included were 810 participants in the Epidemiological Investigation of Rheumatoid Arthritis (EIRA) in Sweden who answered questionnaires including diet (normal/Mediterranean/vegetarian/vegan/low glycemic index/other) and omega-3 supplement use at diagnosis, 1 year, and 3 years post-diagnosis. Prevalence of diet changes and supplement use were assessed. Logistic regression was used to analyze associations between changing diet post-diagnosis, omega-3 supplement use, and the lifestyle/demographic characteristics of education, sex, age, BMI, smoking, and pre-diagnosis diet.

Results:

Between 1999 and 2016, 810 EIRA participants (women: 74%, median age at inclusion:  58 (min 17-max 85), median BMI at inclusion 25.1 (min 15.5-max 50.1), university degree holders: 30%). The proportion of participants with a non-normal diet increased from 23% in 2008 to 30% in 2013. 26% reported a major change in diet within 3 years post-diagnosis (Table). Those who made a change were more likely to be younger (OR 0.98 per year of age, 95% CI 0.96-0.99), have a university education (OR 1.89, 95% CI1.28-2.80), be women (OR 1.77, 95% CI 1.28-2.80), be obese (OR 2.28, 95% CI 1.38-3.78), and have an non-normal diet at baseline (OR 2.81, 95% CI 1.36-5.79 for vegetarian; OR 10.12, 95% CI 5.79-17.71 for Mediterranean; OR 24.82, 95% CI 8.09-76.1 for others). Omega-3 supplement use increased from 20.4% at baseline to 30.9% at one year and decreased to 11.9% three years post-diagnosis. Participants were more likely to both change diets and use omega-3 supplements if they were younger (OR 0.98 per year increase, 95% CI 0.96-0.99), following an alternative diet at baseline (12.0, 95% CI 6.61-21.6), or obese (OR 2.05, 95% CI 1.09-3.88).

Conclusion:

Many RA patients change their diets or use supplements after diagnosis. To better target messaging about these complementary therapies, it may be beneficial to consider them by the sociodemographic and lifestyle characteristics that distinguish them.


Disclosure: M. Lancelot, None; O. Grimaud, None; S. Saevarsdottir, None; J. Askling, MSD, BMS, Pfizer, AbbVie, SOBI, UCB, Roche, Lilly, AstraZeneca, 2; L. Klareskog, None; L. Alfredsson, None; C. Bengtsson, None.

To cite this abstract in AMA style:

Lancelot M, Grimaud O, Saevarsdottir S, Askling J, Klareskog L, Alfredsson L, Bengtsson C. Diet Change and Omega-3 Supplementation in the First Three Years Following a Diagnosis with Rheumatoid Arthritis in Sweden [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/diet-change-and-omega-3-supplementation-in-the-first-three-years-following-a-diagnosis-with-rheumatoid-arthritis-in-sweden/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/diet-change-and-omega-3-supplementation-in-the-first-three-years-following-a-diagnosis-with-rheumatoid-arthritis-in-sweden/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology